Moneycontrol PRO
HomeNewsIndiaCOVID-19 | Indigenous nasal vaccines could be game changer, says WHO chief scientist Dr Soumya Swaminathan

COVID-19 | Indigenous nasal vaccines could be game changer, says WHO chief scientist Dr Soumya Swaminathan

Rapid vaccination of the population is being seen as an effective way to curb the further spread of COVID-19. However, India is currently not inoculating children or individuals below the age of 18.

May 23, 2021 / 16:18 IST
Soumya Swaminathan says schools should be reopened only when the risk of community transmission is low.

Amidst rising cases of COVID-19, World Health Organization (WHO) chief scientist Dr Soumya Swaminathan said that nasal vaccines, which are being made in India, could be a game-changer for children. As per medical experts, the third wave of COVID-19 disease which is expected to hit the country next year is likely to affect children more than the first two waves.

Speaking about the nasal vaccines which are expected to be available next year, Swaminathan said: “Some of the nasal vaccines that are going to be made in India could be game changers for children — easy to administer, will give you local immunity in the respiratory tract."

According to Swaminathan, a paediatrician and clinical scientist, teachers especially should be vaccinated and schools be reopened only when the risk of community transmission is low. “I am very hopeful that ultimately we’ll have a vaccine for children. But that’s not going to happen this year, and we should open schools when community transmission is down. That’s what the rest of the countries have done, with other precautions. And if teachers are vaccinated, that would be a big step forward," she told CNN News18.

Rapid vaccination of the population is being seen as an effective way to curb the further spread of COVID-19. However, India is currently not inoculating children or individuals below the age of 18.

The medical community has been calling for effective and safe doses for children before the third wave arrives. In the United States, Pfizer’s jab has already been approved for use for children between the age of 12 and 15.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

Currently, Zydus' ZyCoV-D and Bharat Biotech’s Covaxin (already being used for adults) are under trial for children above the age of 12 in India.

Recently, National Commission for Protection of Child Rights, in a letter addressed to the Union Health Secretary Rajesh Bhushan pointed out how the third wave could affect children.

"There are guidelines on the management of the newborn in a maternity ward and in the Neonatal Intensive Care Unit (NICU), but there is an urgent need to reorganise a Neonatal/Children Emergency Transport Service (NETS) to prepare specifically for neonatal and children for the third wave of COVID-19," it stated.

"Keeping in view high risk involved for infants and children in the upcoming third wave of COVID-19, you are requested to kindly issue necessary directions for emergency transport services/ambulances suitable for children and neonatals," the child rights' body added.

Moneycontrol News
first published: May 23, 2021 04:18 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347